Cargando…

Platelets Increase the Expression of PD-L1 in Ovarian Cancer

SIMPLE SUMMARY: One-third of patients with ovarian cancer have elevated platelet counts associated with a poor prognosis. We found that platelets increase the expression of immune checkpoint (PD-L1) in ovarian cancer in mice and patients. Reducing platelet counts or inhibiting platelet function redu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Min Soon, Lee, Hani, Gonzalez-Delgado, Ricardo, Li, Dan, Sasano, Tomoyuki, Carlos-Alcalde, Wendolyn, Ma, Qing, Liu, Jinsong, Sood, Anil K., Afshar-Kharghan, Vahid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139585/ https://www.ncbi.nlm.nih.gov/pubmed/35626102 http://dx.doi.org/10.3390/cancers14102498

Ejemplares similares

Lipid profile of platelets and platelet-derived microparticles in ovarian cancer
por: Hu, Qianghua, et al.
Publicado: (2016)

Platelets in pulmonary vascular physiology and pathology
por: Kroll, Michael H., et al.
Publicado: (2012)

Human tumor microenvironment chip evaluates the consequences of platelet extravasation and combinatorial antitumor-antiplatelet therapy in ovarian cancer
por: Saha, Biswajit, et al.
Publicado: (2021)

Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective
por: Menter, David G., et al.
Publicado: (2022)

Platelet activation leads to activation and propagation of the complement system
por: del Conde, Ian, et al.
Publicado: (2005)

The Provocative Roles of Platelets in Liver Disease and Cancer
por: Kanikarla Marie, Preeti, et al.
Publicado: (2021)

Anticomplement therapy
por: Kulkarni, Prathit A, et al.
Publicado: (2008)

Platelets reduce anoikis and promote metastasis by activating YAP1 signaling
por: Haemmerle, Monika, et al.
Publicado: (2017)

Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer
por: Glassman, Deanna, et al.
Publicado: (2022)

Role of Factor Xa Inhibitors in Cancer-Associated Thrombosis: Any New Data?
por: Zalpour, Ali, et al.
Publicado: (2011)

Heparin-induced thrombocytopenia among patients of a comprehensive cancer center
por: Wu, Weixin, et al.
Publicado: (2014)

Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2021)

Autocrine Effects of Tumor-Derived Complement
por: Cho, Min Soon, et al.
Publicado: (2014)

Interactions between Platelets and Tumor Microenvironment Components in Ovarian Cancer and Their Implications for Treatment and Clinical Outcomes
por: Oncul, Selin, et al.
Publicado: (2023)

The Interaction between Factor H and Von Willebrand Factor
por: Feng, Shuju, et al.
Publicado: (2013)

Integrated Analysis of Gene Expression and Tumor Nuclear Image Profiles Associated with Chemotherapy Response in Serous Ovarian Carcinoma
por: Liu, Yuexin, et al.
Publicado: (2012)

Association between abnormal lipid profile and inflammation and progression of myelodysplastic syndrome to acute leukemia
por: Qiao, Wei, et al.
Publicado: (2022)

Taller para la elaboración de productos lácteos en la comunidad de Xico Viejo, Veracuz.
por: Martínez Sáenz, Wendolyn
Publicado: (2017)

Uso de métodos anticonceptivos en los estudiantes de la Facultad de Medicina de Veracruz
por: Reyes Rosado, Wendolyn
Publicado: (2012)

Markers of Angiogenesis in Ovarian Cancer
por: Merritt, William M., et al.
Publicado: (2007)

Successful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Review of the Literature
por: Pemmaraju, Naveen, et al.
Publicado: (2015)

Comparison of clinical utilities of the platelet count and platelet-lymphocyte ratio for predicting survival in patients with cervical cancer: a single institutional study and literature review
por: Kozasa, Katsumi, et al.
Publicado: (2017)

5-HT1A Receptor Function Makes Wound Healing a Happier Process
por: Sadiq, Alia, et al.
Publicado: (2018)

Spatially resolved transcriptomics of high-grade serous ovarian carcinoma
por: Stur, Elaine, et al.
Publicado: (2022)

Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System
por: Lorenz, Carrie, et al.
Publicado: (2018)

Targeting polyploid giant cancer cells potentiates a therapeutic response and overcomes resistance to PARP inhibitors in ovarian cancer
por: Zhang, Xudong, et al.
Publicado: (2023)

Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer
por: Drakes, Maureen L., et al.
Publicado: (2018)

Hyperadhesive von Willebrand Factor Promotes Extracellular Vesicle-Induced Angiogenesis: Implication for LVAD-Induced Bleeding
por: Yang, Mengchen, et al.
Publicado: (2022)

Immunotherapy in Ovarian Cancer: Thinking Beyond PD-1/PD-L1
por: Chardin, Laure, et al.
Publicado: (2021)

Expression and prognostic value of PD-L1 and PD-L2 in ovarian cancer
por: Xue, Chunyan, et al.
Publicado: (2019)

Focus on PD-1/PD-L1 as a Therapeutic Target in Ovarian Cancer
por: Dumitru, Adrian, et al.
Publicado: (2022)

Effect of intra-ovarian platelet rich plasma in women with poor ovarian response
por: Davari tanha, Fatemeh, et al.
Publicado: (2023)

Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer
por: Patel, Ami, et al.
Publicado: (2021)

Rucaparib in ovarian cancer: an update on safety, efficacy and place in therapy
por: Dal Molin, Graziela Z., et al.
Publicado: (2018)

Current Advances in PD-1/PD-L1 Blockade in Recurrent Epithelial Ovarian Cancer
por: Zhang, Yuedi, et al.
Publicado: (2022)

Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia
por: Kumar, Bijender, et al.
Publicado: (2022)

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
por: Zaslavsky, Alexander B., et al.
Publicado: (2020)

Platelet protein biomarker panel for ovarian cancer diagnosis
por: Lomnytska, Marta, et al.
Publicado: (2018)

Trends of low-grade serous ovarian carcinoma in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

Bilateral ovarian fibroma associated with Gorlin syndrome
por: Aram, Shahnaz, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_cqo2t72e8kcq91craboa5ghs8l